Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 25, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	2,728	2,300	1,323	537	1,632	867	Upgrade
Market Cap Growth	73.94%	73.94%	146.40%	-67.12%	88.22%	352.15%	Upgrade
Enterprise Value	2,205	1,728	1,002	274	1,286	674	Upgrade
Last Close Price	44.85	38.60	22.93	10.91	34.20	20.16	Upgrade
PE Ratio	10.35	8.36	-	-	-	-	Upgrade
PS Ratio	6.36	5.30	22.04	20.19	59.67	30.29	Upgrade
PB Ratio	4.05	3.41	3.93	2.49	5.44	3.10	Upgrade
P/TBV Ratio	4.08	3.41	3.93	2.49	5.44	3.10	Upgrade
P/FCF Ratio	15.06	12.59	-	-	-	-	Upgrade
P/OCF Ratio	14.95	12.49	-	-	-	-	Upgrade
EV/Sales Ratio	5.08	3.98	16.69	10.29	47.01	23.53	Upgrade
EV/EBITDA Ratio	8.69	6.81	-	-	-	-	Upgrade
EV/EBIT Ratio	8.72	6.84	-	-	-	-	Upgrade
EV/FCF Ratio	12.06	9.45	-	-	-	-	Upgrade
Debt / Equity Ratio	0.02	0.02	0.00	0.02	0.02	0.02	Upgrade
Debt / EBITDA Ratio	0.04	0.04	-	-	-	-	Upgrade
Debt / FCF Ratio	0.06	0.06	-	-	-	-	Upgrade
Asset Turnover	0.79	0.79	0.20	0.09	0.08	0.12	Upgrade
Quick Ratio	12.39	12.39	16.54	7.61	7.55	7.69	Upgrade
Current Ratio	12.48	12.48	16.71	7.80	7.74	7.84	Upgrade
Return on Equity (ROE)	54.39%	54.39%	-28.59%	-49.41%	-43.32%	-36.79%	Upgrade
Return on Assets (ROA)	28.66%	28.66%	-19.32%	-27.57%	-23.40%	-16.82%	Upgrade
Return on Capital (ROIC)	30.86%	30.86%	-21.01%	-31.27%	-26.60%	-21.08%	Upgrade
Return on Capital Employed (ROCE)	36.30%	36.30%	-	-	-	-	Upgrade
Earnings Yield	10.00%	11.96%	-5.97%	-23.73%	-7.69%	-7.63%	Upgrade
FCF Yield	6.64%	7.95%	-5.36%	-20.29%	-6.68%	-8.41%	Upgrade
Buyback Yield / Dilution	-14.65%	-14.65%	-15.74%	-5.87%	-34.67%	-32.84%	Upgrade

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q